Skip to content
healthcare.dev

Olopatadine Hydrochloride Ophthalmic Solution

NDC 83324-120, Olopatadine Hydrochloride Ophthalmic, solution, from Chain Drug Marketing Association INC.

Product NDC
83324-120
Status
Listed
Labeler
Chain Drug Marketing Association INC
Dosage form
SOLUTION
Route
OPHTHALMIC
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA209752
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83324-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLOPATADINE HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Decreased Histamine Release [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Mast Cell Stabilizer [EPC]

Package NDCNDC-11Package
83324-120-25833240120251 BOTTLE, PLASTIC in 1 CARTON (83324-120-25) / 2.5 mL in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 83324012025

    GET /v1/drugs/nadac/83324012025

Use it

Look up 83324-120 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83324-120 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83324-120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.